checkAd
    Startseite > Aktien > Sutro Biopharma > Nachrichten
    Sutro Biopharma Aktie
    3,5200
     
    USD
    +2,92 %
    +0,1000 USD
    Letzter Kurs 02:00:00 Nasdaq
    3,5000
     
    USD
    6.100 STK
    Geldkurs 29.04.24
    3,5200
     
    USD
    11.800 STK
    Briefkurs 29.04.24
    ISIN: US8693671021 · WKN: A2N6SG · SYM: STRO · USA

    Neueste Nachrichten

    Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
    02.04.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
    25.03.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma to Participate in Upcoming Investor Conferences
    06.02.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC
    04.01.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024
    14.12.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer
    21.11.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
    13.11.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023
    22.10.23 · globenewswire · Sutro Biopharma
    Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference
    16.10.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer
    19.09.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma to Participate in Upcoming Investor Conferences
    30.08.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
    10.08.23 · globenewswire · Sutro Biopharma